Product
Cefazolin
Aliases
Cefazolin 3gm for Injection USP and Dextrose Injection USP, Cefazolin 3gm in DUPLEX (50ml)
Name
Cefazolin
INN Name
cefazolin sodium
FDA Approved
Yes
27 clinical trials
12 organizations
50 indications
1 document
Indication
InfectionsIndication
HealthyIndication
Prosthetic Joint InfectionIndication
InfectionIndication
Prosthesis RelatedIndication
Joint InfectionIndication
Surgical SiteIndication
SSIsIndication
Infection ProIndication
PeritonitisIndication
Staphylococcal BacteraemiaIndication
FractureIndication
OpenIndication
Thoracic Surgical ProceduresIndication
Antibiotic ProphylaxisIndication
Surgical ProphylaxisIndication
Surgical Site InfectionIndication
Vascular Access PortsIndication
Supracondylar Humerus FractureIndication
Postoperative Wound InfectionIndication
Knee ArthropathyIndication
Arthropathy of KneeIndication
Surgical Site InfectionsIndication
ScoliosisIndication
Non-healing WoundIndication
Hemodialysis ComplicationIndication
Infectious DiseaseIndication
End-Stage Renal DiseaseIndication
Microbial ColonizationIndication
adverse effect of antibioticsIndication
Cesarean Section ComplicationsIndication
ObesityIndication
IOL Affected Fetus/NewbornIndication
Pacemaker ComplicationIndication
Propionibacterium InfectionIndication
Peritoneal Dialysis Catheter InfectionIndication
Peritoneal Dialysis ComplicationIndication
Staphylococcus aureus bacteremiaIndication
Cutaneous Melanoma AJCC v8Indication
Cutaneous MelanomaIndication
Cutaneous Melanoma (Clinical Stage IB)Indication
Stage I Cutaneous Melanoma AJCC v8Indication
Stage IA Cutaneous Melanoma AJCC v8Indication
MelanomaIndication
Stage IIA Cutaneous MelanomaClinical trial
A Phase 1, Open-Label, Single-Dose Study to Evaluate the Pharmacokinetics of a Single 3 Gram Dose of Cefazolin in Adult Subjects Weighing >= 120 kg Scheduled for SurgeryStatus: Completed, Estimated PCD: 2023-07-13
Clinical trial
Pharmacokinetic Study of Cefazolin 3 g/150 mL in Subjects Weighing Greater Than or Equal to 120 kg Versus Cefazolin 2 g/100 mL in Subjects Weighing Less Than 120 kgStatus: Completed, Estimated PCD: 2022-08-30
Clinical trial
Multiple Doses Versus Single Dose of Cefazolin to Prevent Periprosthetic Joint Infection After Revision Arthroplasty: a Multicenter Open-label, Randomized Clinical Trial.Status: Active (not recruiting), Estimated PCD: 2023-12-01
Clinical trial
A Multicenter Non-inferiority Randomized Trial Comparing Cloxacillin Versus Cefazolin Efficacy for the Treatment of Bacteremia Caused by Methicillin-susceptible Staphylococcus Aureus (MSSA)Status: Active (not recruiting), Estimated PCD: 2024-06-01
Clinical trial
Single Versus Combined Antibiotic Therapy for Bacterial Peritonitis in Continuous Ambulatory Peritoneal Dialysis PatientsStatus: Completed, Estimated PCD: 2013-12-01
Clinical trial
Dalbavancin as an Option for Treatment of S. Aureus Bacteremia (DOTS): A Phase 2b, Multicenter, Randomized, Open-Label, Assessor-Blinded Superiority Study to Compare the Efficacy and Safety of Dalbavancin to Standard of Care Antibiotic Therapy for the Completion of Treatment of Patients With Complicated S. Aureus BacteremiaStatus: Completed, Estimated PCD: 2023-10-06
Clinical trial
Prevention of Infections in Cardiac Surgery: a Cluster-randomized Factorial Cross-over TrialStatus: Active (not recruiting), Estimated PCD: 2026-08-07
Clinical trial
Comparison of a Morphomic-Based to the Standard-of-Care-Based Cefazolin Dose for Antimicrobial ProphylaxisStatus: Recruiting, Estimated PCD: 2024-09-01
Clinical trial
The Use of Single Dose vs Short-Term Peri-Operative Cefazolin in the Prevention of Surgical Site Infection Following Orthognathic SurgeryStatus: Recruiting, Estimated PCD: 2026-07-01
Clinical trial
A Randomized, Double Blind, Placebo-controlled Clinical Trial Assessing the Utility of Antibiotic Prophylaxis Prior to Totally Implanted Venous Access Device (TIVAD) InsertionStatus: Withdrawn, Estimated PCD: 2027-03-01
Clinical trial
Antibiotics Usage in Pediatric Orthopaedic Percutaneous Surgery (APOPS)Status: Completed, Estimated PCD: 2023-03-10
Clinical trial
Analgesia After Total Knee Arthroplasty: Adductor Canal Block With Periarticular Injection and IPACK (ACB/PAI/IPACK) Versus Periarticular Injection (PAI). A Double-Blinded Randomized Controlled TrialStatus: Completed, Estimated PCD: 2018-05-31
Clinical trial
Perioperative Antibiotic Prophylaxis in Patients Undergoing Elective Total Knee Arthroplasty: A Prospective, Randomized, Open-label, Controlled Multi-center TrialStatus: Recruiting, Estimated PCD: 2024-10-01
Clinical trial
A Cluster-randomized Factorial Crossover Trial, Comparing Antibiotic Mono-prophylaxis With Cefazolin vs. Dual-prophylaxis With Cefazolin Plus Vancomycin and Conventional Wound Dressing vs. Prevena Negative-pressure Wound ManagementStatus: Active (not recruiting), Estimated PCD: 2023-04-27
Clinical trial
Skeletal Muscle and Adipose Tissue Concentrations of Cefazolin Comparing Two Different Dosing Regimens During Pediatric Posterior Spinal Fusion SurgeryStatus: Completed, Estimated PCD: 2022-06-23
Clinical trial
A Phase 2 Randomized Study Comparing Subcutaneous Tumescent Antibiotic Administration With Standard of Care for the Treatment of Chronic WoundsStatus: Not yet recruiting, Estimated PCD: 2027-03-25
Clinical trial
Pharmacokinetic Evaluation of Cefazolin, Ceftazidime, and Ciprofloxacin in Chronic Hemodialysis PatientsStatus: Completed, Estimated PCD: 2024-04-30
Clinical trial
Timing of Umbilical Cord Clamping During an Elective Caesarean Delivery and Its Association With Neonatal Gut Microbiome.Status: Completed, Estimated PCD: 2022-10-01
Clinical trial
Antibiotic Prophylaxis to Prevent Obesity-Related Induction Complications in Nulliparae at Term (APPOINT): A Pilot Randomized Controlled TrialStatus: Completed, Estimated PCD: 2021-06-01
Clinical trial
Comparison Effect Between a Single Dose Prophylaxis Antibiotics Given One Day and Three Days Towards Healing and Risk of Infection in Permanent Pacemaker (PPM) Installation: a Preliminary StudyStatus: Recruiting, Estimated PCD: 2024-09-01
Clinical trial
Multicentre, Adaptive, Double-blind, Three-arm, Placebo-controlled, Noninferiority Trial Examining Antimicrobial Prophylaxis Duration in Cardiac SurgeryStatus: Recruiting, Estimated PCD: 2027-01-01
Clinical trial
Antimicrobial Prophylaxis for Skin Colonization With Propionibacterium Acnes in Primary Open Shoulder Surgery: A Double Blinded Randomized Controlled TrialStatus: Recruiting, Estimated PCD: 2024-12-01
Clinical trial
24 Versus 48 Hours of First Generation or Second Generation Cephalosporin as Prophylaxis to Reduce Surgical Site Infection in Adult Cardiac Surgery Patients: a Randomized Controlled TrialStatus: Completed, Estimated PCD: 2022-05-31
Clinical trial
Comparison Between Post - Surgical Intraperitoneal Antibiotics Administration Vs. Intravenous Pre- Surgical Administration for the Prevention of Peritonitis After Insertion of Peritoneal Dialysis Catheter in Peritoneal Dialysis PatientsStatus: Recruiting, Estimated PCD: 2023-12-31
Clinical trial
Staphylococcus Aureus Network Adaptive Platform TrialStatus: Recruiting, Estimated PCD: 2028-12-01
Clinical trial
Evaluating the Impact of Perioperative Antibiotic Prophylaxis on the Microbiome in Patients With Cutaneous MalignancyStatus: Active (not recruiting), Estimated PCD: 2027-02-02
Document
DailyMed Label: CefazolinOrganization
Physicians Total Care, Inc.Organization
Dispensing Solutions, Inc.Organization
WG Critical Care, LLCOrganization
Sagent PharmaceuticalsOrganization
Henry Schein, Inc.Organization
Proficient Rx LPOrganization
General Injectables & Vaccines, Inc.Organization
Medical Purchasing Solutions, LLCOrganization
Civica, Inc.Organization
Apotex Corp.Organization
Henry Schein Inc.Organization
General Injectables and Vaccines, Inc.